New Alzheimer’s drug met with hope and skepticism
Biogen Inc doctor looks at scans. The US Food and Drug Administration issued accelerated approval for the experimental drug Aduhelm. Source: BIOGEN/AAP
It's the first drug that US regulators say might help slow the disease.
Share
